FDA Inspection 1279132 — LifeSource-Upper Midwest OPO
The FDA completed an inspection of LifeSource-Upper Midwest OPO on Jul 30, 2025 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 30, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Minneapolis, MN (United States)